| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0003 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0004 |